NASDAQ:PANA

Panacea Acquisition Corp. II Stock Forecast, Price & News

$9.63

-0.03 (-0.31%)

(As of 01/27/2022 12:00 AM ET)

Add

Compare

Today's Range: $9.62
▼
$9.65
50-Day Range: $5.62
▼
$9.82
52-Week Range: $9.60
▼
$10.23

Volume: 201,200 shs
Average Volume: 112,077 shs
Market Capitalization: $171.37 million

P/E Ratio: N/A
Dividend Yield: N/A
Beta: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive PANA News and Ratings via Email

Sign-up to receive the latest news and ratings for Panacea Acquisition Corp. II and its competitors with MarketBeat's FREE daily newsletter.

About Panacea Acquisition Corp. II

Panacea Acquisition Corp. II intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in the biotechnology sector. The company was incorporated in 2021 and is based in San Francisco, California.

Panacea Acquisition Corp. II (PANA)
August 8, 2021 | finance.yahoo.com

Panacea Acquisition Corp. II Cl A
April 18, 2021 | marketwatch.com

BRIEF-Panacea Acquisition Corp. II Announces Pricing Of $150 Mln Initial Public Offering
April 7, 2021 | msn.com

Panacea Acquisition Corp. II Announces Pricing of $150,000,000 Initial Public Offering
April 7, 2021 | finance.yahoo.com

Panacea Acquisition Corp Registered Shs Buy
March 10, 2021 | markets.businessinsider.com

EcoR1 Capital's second SPAC Panacea Acquisition II files for a $150 million IPO
March 9, 2021 | nasdaq.com

Being owned by a billionaire is a struggling newsroom's dream. But it can turn into a nightmare
March 9, 2021 | cnn.com

HP is buying HyperX to boost its gaming accessory business
February 26, 2021 | au.finance.yahoo.com

MSD Partners and Panacea's SPAC Orion Biotech Opportunities files for a $200 million IPO
February 25, 2021 | nasdaq.com

Nuvation Bio Inc
February 15, 2021 | reuters.com

Panacea Acquisition Corp. (PANA)
February 12, 2021 | uk.finance.yahoo.com

School ERP Market Size 2021 by Company, Product introduction, Sales Volume, Revenue, Price, Gross Margin and Forecast to 2025
February 10, 2021 | marketwatch.com

Nuvation Bio Closes Transaction with Panacea, Debuts as Publicly Traded Oncology Company
February 10, 2021 | finance.yahoo.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Holding & other investment offices
Sub-Industry: N/A
Sector: Unclassified
Current Symbol: NASDAQ:PANA
Previous Symbol
CUSIP: N/A
CIK: 1828989
Web: panacea.ecor1cap.com
Phone: N/A
Fax: N/A
Employees: 3
Year Founded: N/A

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Profitability

EPS (Most Recent Fiscal Year): N/A
Net Income: N/A
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: N/A

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.43
Quick Ratio: 3.43

Price-To-Earnings

Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A

Miscellaneous

Outstanding Shares: 17,795,000
Free Float: N/A
Market Cap: $171.37 million
Optionable: Not Optionable

Company Calendar

Today: 1/28/2022
Fiscal Year End: 12/31/2022

MarketRank^™

Overall MarketRank^™

0.33 out of 5 stars

Unclassified Sector

160th out of 637 stocks

Holding & Other Investment Offices Industry

160th out of 594 stocks

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for Panacea Acquisition Corp. II.

0.0 Community Rank

Outperform Votes
Panacea Acquisition Corp. II has received 0 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
Panacea Acquisition Corp. II has received 0 “underperform” votes. (Add your “underperform” vote.)

MarketBeat's community ratings are surveys of what our community members think about Panacea Acquisition Corp. II and other stocks. Vote “Outperform” if you believe PANA will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PANA will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
Panacea Acquisition Corp. II does not currently pay a dividend.
Dividend Growth
Panacea Acquisition Corp. II does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Panacea Acquisition Corp. II insiders have not sold or bought any company stock.
Percentage Held by Institutions
85.57% of the stock of Panacea Acquisition Corp. II is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

Panacea Acquisition Corp. II (NASDAQ:PANA) Frequently Asked Questions

Who are Panacea Acquisition Corp. II's key executives?: Panacea Acquisition Corp. II's management team includes the following people:
Mr. Oleg Nodelman, Chairman & CEO (Age 44)
Mr. Scott Eric Perlen, Chief Financial Officer (Age 46)
Mr. Scott Platshon, Chief Operating Officer (Age 30)
Ms. Caroline Stout, Chief Investment Officer (Age 30)
Ms. Sarah Marriott, Sec. & Director (Age 44)
Who are some of Panacea Acquisition Corp. II's key competitors?: Some companies that are related to Panacea Acquisition Corp. II include SPARTAN Acquisition CORP. III (SPAQ), Churchill Capital Corp VI (CCVI), Gores Holdings VII (GSEV), Warburg Pincus Capital Co. I-B (WPCB), NextNav (NN), CF Acquisition Corp. IV (CFIV), Landcadia Holdings IV (LCA), Churchill Capital Corp V (CCV), Mason Industrial Technology (MIT), Fusion Acquisition Corp. II (FSNB), E.Merge Technology Acquisition (ETAC), Douglas Elliman (DOUG), RMG Acquisition Corp. III (RMGC), Valens Semiconductor (VLN) and GO Acquisition (GOAC).
View all of PANA's competitors.
When did Panacea Acquisition Corp. II IPO?: (PANA) raised $150 million in an IPO on Wednesday, April 7th 2021. The company issued 15,000,000 shares at a price of $10.00 per share. Cowen served as the underwriter for the IPO.
What is Panacea Acquisition Corp. II's stock symbol?: Panacea Acquisition Corp. II trades on the NASDAQ under the ticker symbol "PANA."
How do I buy shares of Panacea Acquisition Corp. II?: Shares of PANA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Panacea Acquisition Corp. II's stock price today?: One share of PANA stock can currently be purchased for approximately $9.63.
How much money does Panacea Acquisition Corp. II make?: Panacea Acquisition Corp. II has a market capitalization of $171.37 million.
How many employees does Panacea Acquisition Corp. II have?: Panacea Acquisition Corp. II employs 3 workers across the globe.
What is Panacea Acquisition Corp. II's official website?: The official website for Panacea Acquisition Corp. II is panacea.ecor1cap.com.
Where are Panacea Acquisition Corp. II's headquarters?: Panacea Acquisition Corp. II is headquartered at 357 TEHAMA STREET FLOOR 3, SAN FRANCISCO CA, 94103.
How can I contact Panacea Acquisition Corp. II?: Panacea Acquisition Corp. II's mailing address is 357 TEHAMA STREET FLOOR 3, SAN FRANCISCO CA, 94103. The company can be reached via email at [email protected].

This page was last updated on 1/28/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms

Panacea Acquisition Corp. II Stock Forecast, Price & News

About Panacea Acquisition Corp. II

Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Company Calendar

MarketRank™

Overall MarketRank™

0.0 Analyst's Opinion

Consensus Rating

0.0 Community Rank

Outperform Votes

Underperform Votes

0.0 Dividend Strength

Dividend Yield

Dividend Growth

1.7 Company Ownership

Insider Buying vs. Insider Selling

Percentage Held by Institutions

0.0 Earnings and Valuation

Panacea Acquisition Corp. II (NASDAQ:PANA) Frequently Asked Questions

Who are Panacea Acquisition Corp. II's key executives?

Who are some of Panacea Acquisition Corp. II's key competitors?

When did Panacea Acquisition Corp. II IPO?

What is Panacea Acquisition Corp. II's stock symbol?

How do I buy shares of Panacea Acquisition Corp. II?

What is Panacea Acquisition Corp. II's stock price today?

How much money does Panacea Acquisition Corp. II make?

How many employees does Panacea Acquisition Corp. II have?

What is Panacea Acquisition Corp. II's official website?

Where are Panacea Acquisition Corp. II's headquarters?

How can I contact Panacea Acquisition Corp. II?